Can Lowe’s Board of Directors Help the Company Staunch its Red Ink?

(NewsVisual, powered by IntellectSpace) -- Perhaps as collateral damage in the more general downturn of the housing market, Lowe’s Companies Inc (NYSE:  LOW) said in a press release on Monday that it suffered a 33.4 percent decline in net earnings compared with the same period last year, which amounts to $408 million loss.

The company’s Board of Directors, however, has the collective business experience necessary to advise its Management Team on the right steps to take to turn its balance sheet around.

The IntellectSpace Knowledge Map shows, for example, that Lowe’s Director Marshall O Larsen is also the CEO/Chairman for Goodrich Corp.  In that position, Mr Larsen would certainly have familiarity with managing a large company’s finance and know what cost-cutting techniques might be prudent.

Likewise, Director Robert A Ingram is a former CEO/COO/President/Vice Chairman of GlaxoSmithKline Plc, which means he’s knowledgeable about how to manage a large scale company.  He’s also currently on serving on several corporate boards, including as the Chairman of OSI Pharmaceuticals Inc and as a Director of Edwards Life Sciences Corporation and Wachovia Corp.

These latter affiliations suggest that Mr. Ingram keeps up to date on worldwide economic developments, and thus he could be a valuable adviser to Lowe’s Management Team.

In addition, Lowe’s Director O Temple Sloan Jr also serves as a Director for the Bank of America, where he would be privy to the latest data on the credit markets.  His insights could also help Lowe’s to manage its turnaround.

(Note: the information contained and presented in Knowledge Maps is public information from the Securities and Exchange Commission of the United States of America).

Click here for an interactive version of this IntellectSpace Knowledge Map.